Featured Oncology News
Stemming from the user preference that you set, stay informed and increase your productivity via 27/7 web based access to Ontellitrac and a customized email alert system summarizing the most recent oncology-specific information available.
The Oncology Business Dynamics Learning Platform addresses the need to have a high level of understanding of the non-clinical issues that are influencing the decision making process for hem/oncs today.
Sorry. No data so far.
Pipeline Online is the most comprehensive and up to date oncology pipeline information resource that is widely available on the web ...
OBR Finance tracks the market performance of oncology companies and products, and compares our performance versus other indices ...
OBR Radar is a snapshot of upcoming pivotal events in the oncology industry such as FDA action dates, anticipated announcement of pivotal clinical data, and ODAC dates ...
New York, NY
Schaumburg, IL
DC Metro Area
Toronto, Canada
Phoenix, AZ
Phoenix, AZ
Kuala Lumpur, Malaysia
Munich, Germany
San Antonio, TX
Salt Lake City, UT
Boston, MA
Tysons Corner, VA
Dearborn, MI
San Diego, CA
San Antonio, TX
Dallas, TX
Houston, Texas
San Francisco, CA
San Francisco, CA
Santa Monica, CA
Washington, DC
Orlando, FL
Atlanta, GA
Orlando, FL
Denver, CO
Chicago, IL
Lugano, Switzerland
San Francisco, CA
Buenos Aires, Argentina
Featured Content
Previous
News Story Commentary
Meet the Editorial BoardView all Commentary
Dismissing Reduced Abiraterone Dose Is 'Absolutely W...
September 18th 2018 by Tomasz M. Beer, MD, FACP
While there is room for a range of views, this is a situation where there must be room for clinical...
Read More
Medicare Advantage Plan Proposed Use Of Step Therapy...
September 18th 2018 by Thomas Marsland, MD
Delays in accessing the appropriate therapy for patients is a growing problem. Step therapy is just...
Read More
The Secret Drug Pricing System Middlemen Use to Rake...
September 18th 2018 by Winston Wong, PharmD
Spread pricing has been a revenue generating tool for many years. Even I am surprised by the exten...
Read More
Medicare Advantage Plan Proposed Use Of Step Therapy...
September 17th 2018 by William McGivney, PhD
“Your First Chance is Your Best Chance” The title used...
Read More
Progenics Pharmaceuticals Reports Top Line Phase 3 D...
September 13th 2018 by Tomasz M. Beer, MD, FACP
Low sensitivity seen in this trial is a bit of a disappointment. We will need to learn more about ...
Read More
FDA Grants Priority Review to Merck’s Application ...
September 12th 2018 by H. Jack West, MD
The results of KEYNOTE-042 were positive for an OS benefit of pembro over platinum doublet chemo as...
Read More
OBR Green